Ask AI
ProCE Banner Activity

Topical Therapies for Mild to Moderate Atopic Dermatitis: Personalizing Care With New and Emerging Nonsteroidal Treatment Options

Clinical Thought

Learn about new and emerging nonsteroidal topical therapies that are available and how they can be used in managing mild to moderate disease for patients with atopic dermatitis who cannot or prefer not to use topical corticosteroids.

Released: June 13, 2025

Expiration: June 12, 2026

Continue Activity View Activity

Share

Provided by

Provided by Clinical Care Options, LLC, in partnership with Practicing Clinicians Exchange

ProCE Banner

Supporters

Supported by an educational grant from Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc

Partners

Practicing Clinicians Exchange, LLC

ProCE Banner

Faculty Disclosure

Primary Author

Benjamin Ungar, MD: consultant/advisor/speaker: AbbVie, Botanix, Bristol Myers Squibb, Fresenius Kabi, Galderma, Johnson & Johnson, Leo, Lilly, Pfizer, Primus, Sanofi, UCB; researcher (paid to institution): Incyte, Rapt, Sanofi.